Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 5

Results: 23

Correction to: TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism.

Published in:

2023

By:

Zhao, Kaikai;
Jiang, Liyang;
Si, Youjiao;
Zhou, Shujie;
Huang, Zhaoqin;
Meng, Xiangjiao

Publication type:

Correction Notice

Correction to: Let‑7d inhibits intratumoral macrophage M2 polarization and subsequent tumor angiogenesis by targeting IL‑13 and IL‑10.

Published in:

2023

By:

Su, Boxing;
Han, Haibo;
Gong, Yanqing;
Li, Xuesong;
Ji, Chaoyue;
Yao, Jingjing;
Yang, Jianghui;
Hu, Weiguo;
Zhao, Wei;
Li, Jianxing;
Zhang, Gang;
Zhou, Liqun

Publication type:

Correction Notice

Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.

Published in:

2023

By:

Qiao, Tianyun;
Zhao, Jinbo;
Xin, Xiangbing;
Xiong, Yanlu;
Guo, Wenwen;
Meng, Fancheng;
Li, Hui;
Feng, Yangbo;
Xu, Hui;
Shi, Changhong;
Han, Yong

Publication type:

Correction Notice

STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1315, doi. 10.1007/s00262-022-03336-9

By:

Cui, Hao;
Lan, Zhou;
Zou, Ke-long;
Zhao, Yu-Yue;
Yu, Guang-Tao

Publication type:

Article

Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1301, doi. 10.1007/s00262-022-03335-w

By:

Wang, Sizhen;
Zhang, Xiaohui;
Zou, Xuemei;
Wen, Maorong;
Gan, Chi;
Jiang, Xiaochun;
Li, Min;
Shen, Rongxi;
Zhu, Daojun;
Yao, Anlong;
Fang, Yu;
Fox, Bernard A.;
Hu, Hong-Ming;
Yu, Guangjie;
Wang, Xinbo

Publication type:

Article

Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1285, doi. 10.1007/s00262-022-03334-x

By:

Kajiwara, Yoshinori;
Tazawa, Hiroshi;
Yamada, Motohiko;
Kanaya, Nobuhiko;
Fushimi, Takuro;
Kikuchi, Satoru;
Kuroda, Shinji;
Ohara, Toshiaki;
Noma, Kazuhiro;
Yoshida, Ryuichi;
Umeda, Yuzo;
Urata, Yasuo;
Kagawa, Shunsuke;
Fujiwara, Toshiyoshi

Publication type:

Article

Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1273, doi. 10.1007/s00262-022-03332-z

By:

Parajuli, Prahlad;
Rosati, Rayna;
Mamdani, Hirva;
Wright III, Robert E.;
Hussain, Zahin;
Naeem, Aroma;
Dzinic, Sijana;
Polin, Lisa;
Gavande, Navnath S.;
Ratnam, Manohar

Publication type:

Article

Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1261, doi. 10.1007/s00262-022-03330-1

By:

Chen, Cunte;
Liu, Siyang Maggie;
Chen, Yedan;
Ou, Qiuxiang;
Bao, Hua;
Xu, Ling;
Zhang, Yikai;
Zhang, Jia-Tao;
Zhong, Wenzhao;
Zhou, Qing;
Yang, Xue-Ning;
Shao, Yang;
Wu, Yi-Long;
Liu, Si-Yang;
Li, Yangqiu

Publication type:

Article

Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1247, doi. 10.1007/s00262-022-03329-8

By:

Ninkov, Marina;
Schmerk, Crystal L.;
Moradizadeh, Manoosh;
Parvathy, Seema N.;
Figueredo, Rene;
Burton, Jeremy P.;
Silverman, Michael S.;
Fernandes, Ricardo;
Maleki Vareki, Saman;
Haeryfar, S. M. Mansour

Publication type:

Article

Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1061, doi. 10.1007/s00262-022-03328-9

By:

Széles, Ádám;
Fazekas, Tamás;
Váncsa, Szilard;
Váradi, Melinda;
Kovács, Petra Terézia;
Krafft, Ulrich;
Grünwald, Viktor;
Hadaschik, Boris;
Csizmarik, Anita;
Hegyi, Péter;
Váradi, Alex;
Nyirády, Péter;
Szarvas, Tibor

Publication type:

Article

Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1327, doi. 10.1007/s00262-022-03327-w

By:

Kim, Jennie C.;
Liu, Xian;
Fitzgerald, Karen;
Eng, Jason S.;
Orf, Jessica;
O'Brien, Sarah A.;
Belmontes, Brian;
Casbon, Amy-Jo;
Novitskiy, Sergey V.;
Tarbell, Kristin V.;
DeVoss, Jason;
Egen, Jackson G.

Publication type:

Article

Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1199, doi. 10.1007/s00262-022-03326-x

By:

Gu, Yun;
Zhang, Puran;
Wang, Jieti;
Lin, Chao;
Liu, Hao;
Li, He;
He, Hongyong;
Li, Ruochen;
Zhang, Heng;
Zhang, Weijuan

Publication type:

Article

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1233, doi. 10.1007/s00262-022-03322-1

By:

Thangaraj, Jaya Lakshmi;
Jung, Sung-Hoon;
Vo, Manh-Cuong;
Chu, Tan-Huy;
Phan, Minh-Trang Thi;
Lee, Kyung-Hwa;
Ahn, Seo-Yeon;
Kim, Mihee;
Song, Ga-Young;
Ahn, Jae-Sook;
Yang, Deok-Hwan;
Kim, Hyeoung-Joon;
Cho, Duck;
Lee, Je-Jung

Publication type:

Article

Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1185, doi. 10.1007/s00262-022-03321-2

By:

Wotman, Kathryn L.;
Chow, Lyndah;
Martabano, Brittany;
Pezzanite, Lynn M.;
Dow, Steven

Publication type:

Article

Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1225, doi. 10.1007/s00262-022-03320-3

By:

Jain, Aditya;
Zhang, Shijia;
Shanley, Ryan M.;
Fujioka, Naomi;
Kratzke, Robert A.;
Patel, Manish R.;
Kulkarni, Amit A.

Publication type:

Article

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1139, doi. 10.1007/s00262-022-03319-w

By:

Symonds, Alistair L. J.;
Miao, Tizong;
Busharat, Zabreen;
Li, Suling;
Wang, Ping

Publication type:

Article

Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1169, doi. 10.1007/s00262-022-03318-x

By:

Qiao, Tianyun;
Zhao, Jinbo;
Xin, Xiangbing;
Xiong, Yanlu;
Guo, Wenwen;
Meng, Fancheng;
Li, Hui;
Feng, Yangbo;
Xu, Hui;
Shi, Changhong;
Han, Yong

Publication type:

Article

Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1153, doi. 10.1007/s00262-022-03317-y

By:

Susek, Katharina H.;
Schwietzer, Ysabel A.;
Karvouni, Maria;
Gilljam, Mari;
Keszei, Marton;
Hussain, Alamdar;
Lund, Johan;
Kashif, Muhammad;
Lundqvist, Andreas;
Ljunggren, Hans-Gustaf;
Nahi, Hareth;
Wagner, Arnika K.;
Alici, Evren

Publication type:

Article

Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1121, doi. 10.1007/s00262-022-03316-z

By:

Gao, Jianpeng;
Zhao, Zhenxiong;
Zhang, Hena;
Huang, Shenglin;
Xu, Midie;
Pan, Hongda

Publication type:

Article

Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1103, doi. 10.1007/s00262-022-03315-0

By:

Yao, Yunpeng;
Li, Jianhua;
Qu, Kuo;
Wang, Yangeng;
Wang, Zhe;
Lu, Wenting;
Yu, Yongli;
Wang, Liying

Publication type:

Article

Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1089, doi. 10.1007/s00262-022-03313-2

By:

Rutihinda, Cleopatra;
Haroun, Ryma;
Saidi, Nour Elhouda;
Ordoñez, Juan Pablo;
Naasri, Sahar;
Lévesque, Dominique;
Boisvert, François-Michel;
Fortier, Pierre-Hugues;
Belzile, Mathieu;
Fradet, Laurent;
Hubert-Tremblay, Vincent;
Turgeon, Guy Anne;
Wang, Chang Shu;
Delage, Patrick;
Rousseau, Étienne;
Paquette, Benoît;
Oweida, Ayman J.

Publication type:

Article

Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1209, doi. 10.1007/s00262-022-03312-3

By:

Knight, Andrea;
Piskacek, Martin;
Jurajda, Michal;
Prochazkova, Jirina;
Racil, Zdenek;
Zackova, Daniela;
Mayer, Jiri

Publication type:

Article

Local immunotherapy with the RNA-based immune stimulator CV8102 induces substantial anti-tumor responses and enhances checkpoint inhibitor activity.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1075, doi. 10.1007/s00262-022-03311-4

By:

Lutz, Johannes;
Meister, Michael;
Habbeddine, Mohamed;
Fiedler, Katja;
Kowalczyk, Aleksandra;
Heidenreich, Regina

Publication type:

Article